|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.03 USD | -0.62% |
|
+0.10% | -6.35% |
| 05-15 | Oppenheimer Adjusts Price Target on Pelthos Therapeutics to $66 From $62, Maintains Outperform Rating | MT |
| 05-14 | Pelthos Therapeutics Inc., Q1 2026 Earnings Call, May 14, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.62% | +0.10% | +8.89% | +31.42% | -6.35% | +146.02% | - | - | - | 102M | |
| +7.13% | +9.97% | +13.44% | +31.85% | +12.42% | +52.48% | +163.30% | +424.77% | +1,525.35% | 1,006B | |
| +3.99% | +11.50% | +8.67% | +6.14% | +23.05% | +67.23% | +53.89% | +55.08% | +120.24% | 589B | |
| +4.20% | +17.03% | +17.45% | +22.28% | +10.88% | +36.66% | +86.40% | +124.24% | +323.24% | 430B | |
| +0.99% | +5.11% | +0.24% | +7.47% | +2.16% | +29.26% | +21.27% | -2.76% | +39.13% | 331B | |
| +1.82% | +8.85% | +2.89% | +1.82% | +3.83% | +39.72% | +25.35% | +68.47% | +255.15% | 288B | |
| +0.22% | +6.98% | +5.71% | +5.57% | +15.22% | +32.93% | +39.24% | +49.16% | +66.71% | 285B | |
| +0.73% | +13.51% | +10.02% | +34.84% | -2.24% | -26.95% | -41.57% | +24.44% | +84.27% | 213B | |
| +1.56% | +6.14% | +5.61% | +1.24% | +9.48% | +27.82% | +57.78% | +47.66% | +144.68% | 190B | |
| +3.26% | +3.33% | -4.82% | -7.51% | +4.19% | +20.72% | +65.07% | +88.39% | +58.92% | 154B | |
| +2.62% | -3.65% | -6.22% | -10.96% | -2.45% | +0.12% | -36.58% | -37.69% | -28.50% | 135B | |
| +2.32% | +8.79% | +13.08% | +7.99% | +8.38% | +10.21% | +41.60% | +152.82% | +499.93% | 122B | |
| +3.85% | +6.52% | -3.26% | -2.41% | +6.64% | +23.22% | -11.56% | -13.81% | -18.54% | 113B | |
| -0.03% | +3.12% | +3.55% | -3.46% | +8.69% | +42.20% | +39.14% | +12.26% | +7.04% | 104B | |
| +1.78% | +2.36% | -3.09% | -6.23% | -9.25% | -8.74% | -23.86% | -14.93% | +8.22% | 101B | |
| -1.33% | -1.74% | -8.41% | -12.15% | -9.81% | -1.87% | +76.12% | +67.36% | +567.72% | 76.71B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.65% | +0.99% | -0.33% | -12.59% | +5.21% | +16.78% | +10.64% | +35.36% | +23.11% | 49.4B | |
| -2.74% | +0.52% | -1.54% | -10.04% | -18.30% | -8.08% | +4.89% | -28.49% | +233.16% | 48.71B | |
| 0.00% | +26.51% | +22.36% | +23.26% | +26.99% | +77.96% | -6.93% | -9.25% | -46.37% | 52.57B | |
| Average | +0.37% | +4.32% | +4.43% | +5.71% | +4.67% | +30.40% | +31.34% | +57.95% | +214.64% | 217.6B | |
| Weighted average by Cap. | +0.47% | +4.74% | +7.46% | +12.53% | +9.40% | +35.73% | +64.72% | +137.70% | +469.62% |
- Stock Market
- Stocks
- PTHS Stock
- Sector Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
